You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

TATUM-T Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tatum-t patents expire, and what generic alternatives are available?

Tatum-t is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in TATUM-T is copper. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the copper profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TATUM-T?
  • What are the global sales for TATUM-T?
  • What is Average Wholesale Price for TATUM-T?
Summary for TATUM-T
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 2869
Patent Applications: 2,008
DailyMed Link:TATUM-T at DailyMed
Drug patent expirations by year for TATUM-T

US Patents and Regulatory Information for TATUM-T

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TATUM-T

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TATUM-T

See the table below for patents covering TATUM-T around the world.

Country Patent Number Title Estimated Expiration
Canada 941254 INTRAUTERINE CONTRACEPTIVE METHOD ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.